MedPath

Intervention Study to Evaluate the Importance of Information Given to Patients With Contact Allergy

Not Applicable
Completed
Conditions
Dermatitis, Allergic Contact
Interventions
Behavioral: extended information
Registration Number
NCT01953380
Lead Sponsor
Region Skane
Brief Summary

The purpose of this study is to determine whether extended information given to patients with contact allergy improves knowledge, treatment efficacy and daily functioning.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
400
Inclusion Criteria
  • Patients with suspected contact allergy
  • Age above 18 years
  • Participants have given informed consent
Read More
Exclusion Criteria
  • Mental or language disabilities
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
extended informationextended informationExtended information on specific allergy
Primary Outcome Measures
NameTimeMethod
knowledgeone year after inclusion

knowledge about specific contact allergies and exposure, assessed by questionnaire, a modified version of Nordic Occupational Skin Questionnaire NOSQ-2002/Long, and patient records.

Secondary Outcome Measures
NameTimeMethod
clinical improvementone year after inclusion

assessed by questionnaire, a modified version of Nordic Occupational Skin Questionnaire NOSQ-2002/Long, and patient records.

quality of lifeone year after inclusion

assessed by questionnaire, Dermatology Life Quality Index (DLQI).

effect on daily functioningone year after inclusion

assessed by questionnaire, a modified version of Nordic Occupational Skin Questionnaire NOSQ-2002/Long, and Dermatology Life Quality Index (DLQI).

Trial Locations

Locations (1)

Hudmottagningen SUS

🇸🇪

Lund, Skåne, Sweden

© Copyright 2025. All Rights Reserved by MedPath